minimally invasive devices

Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio

The acquisition, expected to be completed this year, will expand global access to Penumbra’s technologies, which include treatments for strokes, pulmonary embolisms, and heart attacks.